Drug Database
Back to search

Netherlands· NL-f0e7a81f6406

Zimbus Breezhaler 114 micrograms/46 micrograms/136 micrograms inhalatie poeder in harde capsules

A indacaterol, glycopyrronium bromid und mometason product containing glycopyrroniumbromide + indacaterolacetaat + mometasonfuroaat, registered in Netherlands by Novartis Europharm Limited. The same ATC class is registered in 11 of our 19 countries.

ATC R03AL12

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedZimbus Breezhaler 114 micrograms/46 m…ATCR03AL12REGISTER NO.NL-f0e7a81f6406PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about glycopyrroniumbromide + indacaterolacetaat + mometasonfuroaatAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Indacaterol, glycopyrronium bromid und mometason is registered in 11 of 19 countries.

Countries holding a registration under ATC R03AL12 (indacaterol, glycopyrronium bromid und mometason), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose
Search indacaterol, glycopyrronium bromid und mometason products by name

Indacaterol, glycopyrronium bromid und mometason · ATC R03AL12

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
GLYCOPYRRONIUMBROMIDE + INDACATEROLACETAAT + MOMETASONFUROAAT
Manufacturer
Novartis Europharm Limited
Country
Netherlands (NL)
ATC code
R03AL12
ATC class
Indacaterol, Glycopyrronium bromid und Mometason
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/20/1440

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Indacaterol, glycopyrronium bromid und mometason in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All indacaterol, glycopyrronium bromid und mometason products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d3e2969a-686c-4c03-9470-ae0846882033
GET /v1/drugs/d3e2969a-686c-4c03-9470-ae0846882033?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Inhalatiepoeder in harde capsule",
  "route": "Inhalatie",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/zimbus-breezhaler-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Indacaterol, glycopyrroinium bromide and mometasone",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp125971",
  "excipients": [
    "CARRAGEENAN (E 407)",
    "HYPROMELLOSE (E 464)",
    "HYPROMELLOSE (E 464)",
    "IJZEROXIDE GEEL (E 172)",
    "IJZEROXIDE ZWART (E 172)",
    "INDIGOKARMIJN (E 132)",
    "KALIUMCHLORIDE (E 508)",
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "PROPYLEENGLYCOL (E 1520)",
    "ZWARTE INKT"
  ],
  "substances": [
    "GLYCOPYRRONIUMBROMIDE",
    "INDACATEROLACETAAT",
    "MOMETASONFUROAAT"
  ],
  "leaflet_url": null,
  "authorised_at": "2020/07/03",
  "procedure_number": "EMEA/H/C/005518",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/20/1440",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about indacaterol, glycopyrronium bromid und mometason.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console